Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which the company ...
Colgate-Palmolive Co. shares are down 4.9% Friday despite the toothpaste and toothbrush giant reporting better-than-expected ...
Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.
Shares of Colgate-Palmolive ( NYSE: CL) are trading defensively ahead of Friday’s opening bell as mixed fourth quarter ...
Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.
2d
SportsLine's model simulated Wednesday's Army Black Knights vs. Colgate Raiders Patriot League college basketball matchup ...
Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...
Colgate-Palmolive Co. (CL) revealed earnings for its fourth quarter that increased from the same period last year and beat the ...
Goldman Sachs analyst Bonnie Herzog maintains a Buy rating on Colgate-Palmolive, with a price target of $106. Despite Q4 EPS of $0.91 exceeding expectations, organic sales growth of 4.3% fell short.
Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback